Peer-reviewedLicence not statedMMWR. Morbidity and mortality weekly report
Effectiveness of Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine in Children Aged 6 Months–6 Years During a Statewide Pertussis Outbreak — Alaska, May–November 2024
Related
- Modelling the health and budget impact of introducing diphtheria-tetanus-pertussis-containing-vaccine booster doses in Uganda
- Delayed introduction, transmission variation and susceptible dynamics explain spatial asynchrony during Republic of Korea's large pertussis outbreak.
- Chemical Fatty Acylation Confers Hemolytic and Toxic Activities to Adenylate Cyclase Protoxin of Bordetella pertussis
- Development and validation of a laboratory-developed test on Panther Fusion(R) system for detection of macrolide resistance in Bordetella pertussis
- Age-Stratified Patterns of Diagnostic Delay in Pertussis
BibTeX
@article{anon2026effectiveness,
title = {{Effectiveness of Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine in Children Aged 6 Months–6 Years During a Statewide Pertussis Outbreak — Alaska, May–November 2024}},
journal = {MMWR. Morbidity and mortality weekly report},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13671722},
}
RIS
TY - JOUR
TI - Effectiveness of Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine in Children Aged 6 Months–6 Years During a Statewide Pertussis Outbreak — Alaska, May–November 2024
PY - 2026
DA - 2026/10/15
JO - MMWR. Morbidity and mortality weekly report
UR - https://europepmc.org/article/PMC/PMC13671722
SN - 0149-2195
SN - 1545-861X
ER -